Windsor Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
3,307
-413
-11% -$141K 0.31% 50
2026
Q1
$1.31M Buy
3,720
+10
+0.3% +$3.56K 0.37% 49
2025
Q4
$1.21M Buy
3,710
+2,117
+133% +$672K 0.34% 49
2025
Q3
$450K Buy
1,593
+65
+4% +$18.9K 0.12% 90
2025
Q2
$427K Buy
1,528
+154
+11% +$43.6K 0.12% 90
2025
Q1
$428K Buy
1,374
+120
+10% +$35.4K 0.13% 91
2024
Q4
$327K Buy
1,254
+11
+0.9% +$3.26K 0.1% 98
2024
Q3
$401K Buy
1,243
+265
+27% +$86.7K 0.12% 94
2024
Q2
$306K Buy
+978
New +$287K 0.09% 96

Other funds holding AMGN

Windsor Capital Management's AMGN Position: Q2 2026 in Review

Windsor Capital Management reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $141K and leaving 3,307 shares worth $1.2M. The position accounts for 0.31% of the portfolio, ranked #50.

Windsor Capital Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.31M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Windsor Capital Management held 3,307 shares of Amgen worth $1.2M as of Q2 2026.
  • Windsor Capital Management sold 413 Amgen shares in Q2 2026, an estimated $141K.
  • Amgen made up 0.31% of Windsor Capital Management's portfolio in Q2 2026, its #50 holding.
  • Windsor Capital Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • Windsor Capital Management's Amgen position peaked at $1.31M in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.